Johnson & Johnson's experimental prostate cancer drug, JNJ-6143, has shown significant tumor shrinkage and reduced PSA levels ...

Zymeworks has entered a global licensing agreement with Roche to develop and commercialize its experimental lung cancer drug ...

A groundbreaking study reveals that Amgen's Imdelltra, when combined with AstraZeneca's immunotherapy Imfinzi, significantly ...

Sun Pharma's Unolxcyt shows a significant objective response rate and durable cancer control for patients with advanced skin ...

The inclusion of Dr. Naresh Trehan in a pharmaceutical marketing review panel faces backlash from patient groups over ...

J.P. Morgan projects that the GLP-1 drug market in China, India, and Brazil could reach $22 billion by 2035, driven by ...

Bristol Myers Squibb reveals a patient death during an early-stage trial of its experimental CAR-T cell therapy for multiple ...

Dr Reddy's Laboratories has introduced two new generic versions of Ozempic, named Obeda Pro and Obeda Plus, to address supply ...

AbbVie announced promising results for its experimental drug lutikizumab in reducing skin lesions from hidradenitis ...

Kilitch Drugs has divested its Ethiopian subsidiary for $14 million, aiming to enhance its manufacturing capabilities in India and enter the lucrative GLP-1 market.

UNICEF and Gavi have agreed to reduce the price of the Mosquirix malaria vaccine by 40%, making it more accessible and ...

Telitacicept met the study's main goal and largely preserved kidney function over two years, while patients on placebo saw a ...